Published on:

FDA Aims to Reduce Foreign Drug Manufacturer Errors

After the heparin contamination last year, the FDA is now forming a pilot program to study 100 applicants in their hopes to promote safety in foreign pharmaceutical ingredients. The heparin contamination was produced by foreign companies where numerous deaths were the result of adverse drug reactions to the substance. The FDA focuses on those companies that pose the highest risk in importing products that disobey FDA’s standards.

For the full story, click here.